Skip to main content
Log in

Matrix metalloproteinase-9 as new biomarkers of severity in multiple organ dysfunction syndrome caused by trauma and infection

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

Multiple organ dysfunction syndrome (MODS) is an important cause of morbidity and mortality in intensive care unit. A severe insult in the form of infection or trauma primes the host immune system so that a subsequent, relatively trivial insult produces systemic inflammation response syndrome, which can lead to MODS and death. Matrix metalloproteinase-9 (MMP-9) is stored in the tertiary granules of polymorphonuclear leukocytes. These cells are key effectors in acute inflammatory diseases, such as sepsis and MODS. Endotoxin leads to rapid release of MMP-9 from these granules in vitro and in vivo. However, the role of this enzyme in MODS, and whether it is associated with organ injury at the early stage of MODS remains unclear. This present work may study role of MMP-9 with the MODS rats that caused by trauma and infection and investigate the mechanism of organ injury at the early stage of MODS. Here, we developed a rat model for MODS caused by trauma and infection and analyzed the dynamic level of MMP-9 and determined the relationship between MMP-9 level and early phase of organ injury in MODS rat. The histological changes in pulmonary, renal, and hepatic tissue were observed by light microscope. The expressions of plasma MMP-9 proteins were detected by an enzyme linked immunosorbent assay and its levels in the pulmonary, renal, and hepatic tissue were detected by using immunohistochemistry, respectively. The results indicated that there were no significant improvements in histopathology of rats in control group. However, the pulmonary, renal, and hepatic damage were serious in MODS groups. The concentration of MMP-9 in plasma and tissues of MODS rats increased markedly at the early stage and were higher than that of the control group. Moreover, the MMP-9 level in plasma positively correlated with the levels of pulmonary, renal, and hepatic tissue. This study clearly shows that MMP-9 is good biomarker to predict the severity of injury organ at the early phase of MODS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Wang H, Ma S (2008) The cytokine storm and factors determining the sequence and severity of organ dysfunction in multiple organ dysfunction syndrome. Am J Emerg Med 26:711–715

    Article  PubMed  Google Scholar 

  2. Dewar DC, Balogh ZJ (2011) The epidemiology of multiple-organ failure: a definition controversy. Acta Anaesthesiol Scand 55:248–249

    Article  PubMed  CAS  Google Scholar 

  3. Mera S, Tatulescu D, Cismaru C et al (2011) Multiplex cytokine profiling in patients with sepsis. APMIS 119:155–163

    Article  PubMed  CAS  Google Scholar 

  4. Hanisch E, Brause R, Paetz J et al (2011) Review of a large clinical series: predicting death for patients with abdominal septic shock. J Intensive Care Med 26:27–33

    Article  PubMed  Google Scholar 

  5. Walsh CR (2005) Multiple organ dysfunction syndrome after multiple trauma. Orthop Nurs 24:324–333

    Article  PubMed  Google Scholar 

  6. Nguyen LN, Nguyen TG (2009) Characteristics and outcomes of multiple organ dysfunction syndrome among severe-burn patients. Burns 35:937–941

    Article  PubMed  Google Scholar 

  7. Bhatia M (2005) Inflammatory response on the pancreatic acinar cell injury. Scand J Surg 94:97–102

    PubMed  CAS  Google Scholar 

  8. Itoh T, Matsuda H, Tanioka M et al (2002) The role of matrix metalloproteinase-2 and matrix metalloproteinase-9 in antibody-induced arthritis. J Immunol 169:2643–2647

    PubMed  CAS  Google Scholar 

  9. Tetlow LC, Adlam DJ, Woolley DE (2001) Matrix metalloproteinase and proinflammatory cytokine production by chondrocytes of human osteoarthritic cartilage: associations with degenerative changes. Arthritis Rheum 44:585–594

    Article  PubMed  CAS  Google Scholar 

  10. George SJ (2000) Therapeutic potential of matrix metalloproteinase inhibitors in atherosclerosis. Expert Opin Investig Drugs 9:993–1007

    Article  PubMed  CAS  Google Scholar 

  11. Ricou B, Nicod L, Lacraz S et al (1996) Matrix metalloproteinases and TIMP in acute respiratory distress syndrome. Am J Respir Crit Care Med 154:346–352

    PubMed  CAS  Google Scholar 

  12. Torii K, Iida K, Miyazaki Y et al (1997) Higher concentrations of matrix metalloproteinases in bronchoalveolar lavage fluid of patients with adult respiratory distress syndrome. Am J Respir Crit Care Med 155:43–46

    PubMed  CAS  Google Scholar 

  13. Yassen KA, Galley HF, Webster NR (2001) Matrix metalloproteinase-9 concentrations in critically ill patients. Anaesthesia 56:729–732

    Article  PubMed  CAS  Google Scholar 

  14. Cuzzocrea S, Mazzon E, Rosanna B et al (2004) Protective effect of M40401, selective superoxide dismutase mimetic, on zymosan-induced nonseptic shock. Crit Care Med 32:157–167

    Article  PubMed  CAS  Google Scholar 

  15. Hu J, Van den Steen PE, Dillen C et al (2005) Targeting neutrophil collagenase/matrix metalloproteinase-8 and gelatinase B/matrix metalloproteinase-9 with a peptidomimetic inhibitor protects against endotoxin shock. Biochem Pharmacol 70:535–544

    Article  PubMed  CAS  Google Scholar 

  16. Nagase H, Visse R, Murphy G (2006) Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res 69:562–573

    Article  PubMed  CAS  Google Scholar 

  17. Maitra SR, Jacob A, Zhou M et al (2010) Modulation of matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 in sepsis. Int J Clin Exp Med 3:180–185

    PubMed  CAS  Google Scholar 

  18. Keck T, Balcom JHt, Fernandez-del Castillo C et al (2002) Matrix metalloproteinase-9 promotes neutrophil migration and alveolar capillary leakage in pancreatitis associated lung injury in the rat. Gastroenterology 122:188–201

    Article  PubMed  CAS  Google Scholar 

  19. Okada S, Kita H, George TJ et al (1997) Migration of eosinophils through basement membrane components in vitro: role of matrix metalloproteinase-9. Am J Respir Cell Mol Biol 17:519–528

    PubMed  CAS  Google Scholar 

  20. Dubois B, Starckx S, Pagenstecher A et al (2002) Gelatinase B deficiency protects against endotoxin shock. Eur J Immunol 32:2163–2171

    Article  PubMed  CAS  Google Scholar 

  21. Paemen L, Jansen PM, Proost P et al (1997) Induction of gelatinase B and MCP-2 in baboons during sublethal and lethal bacteraemia. Cytokine 9:412–415

    Article  PubMed  CAS  Google Scholar 

  22. Maitra SR, Bhaduri S, Valane PD et al (2003) Inhibition of matrix metalloproteinases by chemically modified tetracyclines in sepsis. Shock 20:280–285

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

We thank Professors Chao Chen and Zhi He of the Faculty of the Pharmacology Department and Ling Huang of Three Gorges University Medical of School for their helpful discussions and suggestions on this study.

Conflicts of interest

The authors declare that there are no conflicts of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jun-ming Li.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Teng, L., Yu, M., Li, Jm. et al. Matrix metalloproteinase-9 as new biomarkers of severity in multiple organ dysfunction syndrome caused by trauma and infection. Mol Cell Biochem 360, 271–277 (2012). https://doi.org/10.1007/s11010-011-1066-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11010-011-1066-0

Keywords

Navigation